Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 8,733 | 10,144 | 4,322 | 4,457 | 9,751 |
Cost of Goods | 4,598 | 5,256 | 2,225 | 2,554 | 5,150 |
Gross Profit | 4,135 | 4,888 | 2,097 | 1,903 | 4,601 |
Operating Expenses | 10,225 | 10,764 | 5,961 | 8,669 | 7,861 |
Operating Income | -5,492 | -5,620 | -3,639 | -6,212 | -3,110 |
Interest Expense | 35 | 35 | 89 | 38 | 33 |
Other Income | -1,946 | 2,871 | 1,163 | 5,400 | 8,734 |
Pre-tax Income | -7,473 | -2,784 | -2,565 | -850 | 5,591 |
Income Tax | 5 | 1 | 1 | N/A | 30 |
Net Income Continuous | -7,478 | -2,785 | -2,566 | -850 | 5,561 |
Net Income | $-7,478 | $-2,785 | $-2,566 | $-850 | $5,561 |
EPS Basic Total Ops | -5.60 | -4.05 | -2.26 | -0.90 | 6.60 |
EPS Basic Continuous Ops | -5.60 | -3.95 | -2.26 | -0.90 | 6.50 |
EPS Diluted Total Ops | -5.60 | -3.85 | -2.26 | -0.90 | 6.40 |
EPS Diluted Continuous Ops | -5.60 | -3.94 | -2.26 | -0.90 | 6.49 |
EPS Diluted Before Non-Recurring Items | -4.40 | -2.80 | -4.60 | N/A | N/A |
EBITDA(a) | $-5,226 | $-4,842 | $-3,508 | $-6,080 | $-2,979 |